4528.T
4528.T
JP3197600004
ONO PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 515.785.000.000 486.871.000.000
5.9%
Cost of Revenue 141.716.000.000 147.950.000.000
4.2%
Gross Profit 374.069.000.000 338.921.000.000
10.4%
281.833.000.000 279.173.000.000
1.0%
Operating Income 92.236.000.000 59.748.000.000
54.4%
Pretax Income 92.654.000.000 59.328.000.000
56.2%
Net Income Common Stockholders 69.767.000.000 50.047.000.000
39.4%
-- --
--
-- --
--
ende